Επιλεγμένες Επιστημονικές Δημοσιεύσεις

@article{,

title = {The impact of fascia iliaca compartment block on chronic postsurgical pain in patients undergoing hip fracture repair},

author = {M Diakomi and M Papaioannou and G Georgoudis and E Argyra and A Mela and I Siafaka and A Makris},

doi = {10.1016/j.jclinane.2020.109801},

issn = {0952-8180},

year  = {2020},

date = {2020-01-01},

journal = {J Clin Anesth},

volume = {64},

pages = {109801},

abstract = {STUDY OBJECTIVE: Chronic postsurgical pain (CPSP), i.e. pain persisting >3 months, may appear after any type of surgery. There is a paucity of literature addressing CPSP development after hip fracture repair and the impact of any analgesic intervention on the development of CPSP in patients after hip fracture surgery. This study is the first aiming to examine the impact of ultrasound-guided fascia iliaca compartment block (USG FICB) on the development of CPSP after hip fracture repair. DESIGN: Prospective randomized study. SETTING: Operating room. PATIENTS: 182 patients scheduled for hip fracture surgery. INTERVENTIONS: Patients were randomized to receive a USG FICB (FICB group) or a sham saline injection (sham FICB group), twenty minutes before positioning for spinal anesthesia. MEASUREMENTS: The hip - related characteristic pain intensity (CPI) at 3- months post-surgery was the primary outcome measure. Presence and severity of hip-related pain at 3- and 6-months post-surgery, numeric rating pain scale (NRS) scores at 6, 24, 36, 48 postoperative hours, total 24-hour tramadol PCA administration and timing of the first tramadol dose, were documented as well. MAIN RESULTS: FICB group presented with lower CPI scores 3- months postoperatively (p < 0.01), as well as lower percentage of patients with high-grade CPSP, 3 and 6 months postoperatively (p < 0.001). FICB group also showed significantly lower NRS scores in all instances, lower total 24 - hour tramadol consumption and higher mean time to first tramadol dose (p < 0.05). The overall sample of 182 patients reported a considerably high incidence of hip -related CPSP (60% at 3 months, 45% at 6 months). CONCLUSIONS: USG FICB in the perioperative setting may reduce the incidence, intensity and severity of CPSP at 3 and 6 months after hip fracture surgery, providing safe and effective postoperative analgesia.},

note = {1873-4529 

Diakomi, Maria 

Papaioannou, Marianna 

Georgoudis, George 

Argyra, Erifili 

Mela, Argyro 

Siafaka, Ioanna 

Makris, Alexandros 

Journal Article 

United States 

J Clin Anesth. 2020 Apr 22;64:109801. doi: 10.1016/j.jclinane.2020.109801.},

keywords = {Acute pain, Chronic pain, Lower extremity, PHYSIOLAB},

pubstate = {published},

tppubtype = {article}

}

@article{,

title = {Cross-cultural Adaptation and Psychometric Properties of the Greek Version of the Central Sensitization Inventory},

author = {P Bilika and R Neblett and G Georgoudis and Z Dimitriadis and E Fandridis and N Strimpakos and E Kapreli},

doi = {10.1111/papr.12843},

issn = {1530-7085},

year  = {2020},

date = {2020-01-01},

journal = {Pain Pract},

volume = {20},

number = {2},

pages = {188-196},

abstract = {OBJECTIVES: Recent studies support the opinion that central sensitization (CS) plays an important role in the pathophysiology of many chronic pain conditions. CS refers to hyperexcitability of the central nervous system, which can result in pain hypersensitivity and other somatosensory symptoms. Recognition of CS-related symptomology is crucial in chronic pain evaluation and rehabilitation. The Central Sensitization Inventory (CSI) was created to evaluate symptoms that have been found to be associated with CS. The aim of the current study was the cross-cultural adaptation of the CSI into Greek (CSI-Gr). METHODS: To evaluate discriminate validity, 200 patients with chronic pain and 50 healthy control subjects participated. The sample was divided into 4 diagnostic groups (fibromyalgia, single pain complaints, multiple pain complaints, and a control group) and into 5 CSI severity subgroups, from subclinical to extreme. Convergent validity was determined by evaluation of the relationship between the CSI-Gr and the Pain Catastrophizing Scale (PCS). Additionally, 30 patients completed the CSI a second time for the purpose of a test/retest analysis. RESULTS: The results showed high internal consistency (Cronbach's alpha = 0.994) and test-retest reliability (intraclass correlation coefficient = 0.993). The standard error of measurement was 2.1. The CSI-Gr correlated moderately with the PCS (r = 0.68). Statistically significant differences were found among the 3 comparison groups, with patients who had fibromyalgia reporting the highest CSI severity and healthy control subjects reporting the lowest severity. CONCLUSIONS: As determined in the present study, the CSI-Gr was found to be a reliable and valid tool for recognition of CS-related symptomology.},

note = {1533-2500 

Bilika, Paraskevi 

Neblett, Randy 

Georgoudis, George 

Dimitriadis, Zacharias 

Fandridis, Emmanouil 

Strimpakos, Nikolaos 

Kapreli, Eleni},

keywords = {Central Sensitization Inventory, Chronic pain, cross-cultural adaptation, PHYSIOLAB},

pubstate = {published},

tppubtype = {article}

}